Search

Your search keyword '"Glenthoj, Andreas"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Glenthoj, Andreas" Remove constraint Author: "Glenthoj, Andreas"
82 results on '"Glenthoj, Andreas"'

Search Results

4. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

5. Diagnosis and management of pyruvate kinase deficiency: international expert guidelines

7. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

8. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

10. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective

11. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

12. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

14. Evans syndrome in adults: an observational multicenter study

17. Classification of Α-Thalassemia Data Using Machine Learning Models

19. Molnupiravir Compared to Nirmatrelvir/Ritonavir for COVID-19 in High-Risk Patients with Haematological Malignancy in Europe. A Matched-Paired Analysis from the Epicovideha Registry

20. Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience

24. Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

29. Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey

30. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

31. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

32. Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

33. COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA

34. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

36. Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses

38. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

39. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

40. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

41. Advances in the laboratory diagnosis of hereditary spherocytosis

49. ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19

Catalog

Books, media, physical & digital resources